Registry for patients with Status Epilepticus in critical care

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to create a prospective registry for patients experiencing Convulsive and Non-Convulsive Status Epilepticus (SE) in critical care settings. It involves collecting comprehensive data on patient demographics, seizure characteristics, treatment timelines, and outcomes, including vital status and Glasgow Outcome Scale scores at various time points. The study will utilize standardized forms to ensure consistency in data collection across multiple hospitals. The goal is to better understand the circumstances and treatment of SE in critically ill patients.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* SE defined as 5 min or more of (i) continuous clinical and/or electrographic seizure activity or (ii) recurrent seizure activity without recovery (returning to baseline) between seizures.
* age \>= 18 years

Exclusion Criteria:

* age \< 18 years
* postanoxic status epilepticus

Where it's running

• CH Angouleme - Service de réanimation polyvalente
  Angoulême, France Recruiting
• CH de Beauvais - Service de réanimation polyvalente
  Beauvais, France Recruiting
• CH de Bethune - Service de Réanimation et Surveillance continue
  Beuvry, France Recruiting
• Centre Hospitalier Universitaire Régional
  Brest, France Recruiting
• CH Brive La Gaillarde - Service de réanimation - USC
  Brive-la-Gaillarde, France Recruiting
• CH de Cannes
  Cannes, France Recruiting

Study contacts

• Principal investigator: stephane LEGRIEL, MD — Ictal Group
• Study coordinator: stephane LEGRIEL, MD
• Email: slegriel@ch-versailles.fr
• Phone: +33139639717

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Recovery after coma from serious brain injury or illness

  This observational study will follow adults who are unconscious due to a serious brain illness or injury to see what medical, neurological, psychological, and social factors are linked with recovery over time.

  Recruiting University of California, San Francisco · San Francisco, California · NCT07614074

• Augmented kidney clearance in neurocritical care

  This project will test whether adults in the neuro-ICU with severe brain injury, stroke, seizures, or brain infections have faster kidney clearance (ARC) that can lower antiseizure and antibiotic drug levels.

  Recruiting at 3 sites University of Alberta · Lexington, Kentucky and 2 other locations · NCT07410624

• Ketamine added to levetiracetam to stop prolonged convulsive seizures

  This trial will test whether giving ketamine (two different doses) along with levetiracetam helps stop benzodiazepine-refractory status epilepticus in people age 1 and older.

  Recruiting at 36 sites Phase 3 University of Virginia · Birmingham, Alabama and 62 other locations · NCT06907173

• Improving prognosis for patients with Status Epilepticus

  This study is trying to find blood markers that can help predict how well patients with Status Epilepticus will recover in the ICU and how their thinking skills may change after they leave the hospital.

  Recruiting London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · London, Ontario · NCT06590883

• Using Rapid-Response EEG to Diagnose Seizures in Children

  This study is testing if a new quick EEG device can help doctors diagnose seizures in children faster than the standard method.

  Recruiting Children's Hospital at Montefiore · The Bronx, New York · NCT06564662

• Two-way video support for paramedics caring for infants with life-threatening breathing problems.

  This project will test whether a two-way video link with pediatric emergency doctors helps paramedics give better care to infants with life-threatening breathing problems during transport.

  Recruiting at 4 sites Boston Medical Center · Los Angeles, California and 8 other locations · NCT06441760

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.